Kenvue Inc. Common Stock vs YieldMax TSLA Option Income Strategy ETF — how do they compare? Kenvue Inc. Common Stock trades at $17.68 (market cap $34.06B), while YieldMax TSLA Option Income Strategy ETF trades at $22.45 (market cap $697.51M). The key difference: Kenvue Inc. Common Stock is far larger — about 48.8× YieldMax TSLA Option Income Strategy ETF's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while YieldMax TSLA Option Income Strategy ETF pays none. Which is the better fit depends on your goals.
| KVUE | TSLY | |
|---|---|---|
Market Cap | $34.06B | $697.51M |
Volume | 23,267,228 | 338,271 |
Sector | Consumer Staples | Income / Options Overlay |
52-Week High | $19.83 | $43.35 |
52-Week Low | $14.11 | $20.49 |
Enterprise Value | $41.56B | — |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 43 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TSLY trades at $22.45, down 0.66% with a bullish technical signal supported by moving averages. The ETF maintains consistent weekly dividend distributions averaging $0.21-0.26, though recent analysis highlights concerns about missing Tesla's upside potential. Support levels cluster around $22 with resistance at $23-24, while RSI indicators remain neutral.
The outlook remains mixed with high yield appeal balanced against structural limitations in capturing Tesla's gains. Key risks include Tesla's volatility regime changes and the ETF's option income strategy constraints. Recent analyst downgrades to Hold reflect diminished upside capture potential amid Tesla's extended capex cycle.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →TSLY is an actively managed ETF that seeks to provide high monthly income by employing a synthetic covered call strategy on Tesla, Inc. (TSLA). It does not own Tesla stock directly; instead, it uses a combination of call and put options to simulate long exposure while simultaneously selling call options to collect premiums. It is designed for income-focused investors who are willing to trade TSLA's potential upside for immediate, aggressive yield.
Read more on TSLY →